Clinical Trials

Trial paperwork is where speed and traceability pull against each other. A protocol amendment, a monitoring note or a narrative draft has to be fast and still stand up to inspection. This starter governs the assistant that helps produce them. Participant identifiers are masked on the way out, the answer meets a scored floor, and the captured record holds metadata rather than text.

A study coordinator carries two obligations at once. Participant confidentiality must hold, and the record of what happened must stay defensible to a monitor. Good clinical practice and the electronic records rule both ask who did what and against which record. This starter answers the traffic part of that question.

Before a prompt reaches the model, four checks run in a fixed order. Injection screening comes first so that a planted instruction cannot switch off what follows. The access rule then rejects a call without verified identity claims. A health data check adds record level heuristics to the general redaction stage. Masking covers participant numbers, member numbers and policy or insurance numbers. Free text that names a participant without any number can still pass.

History capture stores metadata only. Prompt and response bodies stay out of that record, which matters at a site that may not retain source documents outside the study system. Blocked requests are captured as well, so a refusal is visible instead of silent. Capture is not set to fail open.

Source checking measures grounding in the returned text and flags a thin citation instead of refusing the answer. Output scoring is the strict gate. A response must reach 0.88 overall, 0.78 for relevance and 0.80 for accuracy, or it is blocked. The review step arrives unset, so nothing escalates until your team defines that rule. Choose the Pharmaceutical Research and Development starter when the work is discovery science rather than a regulated study document.